The National Institutes of Health last month awarded Northwestern University researcher Erik Sontheimer a two-year grant to help him develop siRNAs targeting genes involved in the inhibition of RNA interference.
According to the grant's abstract, such siRNAs could be used to boost the efficacy of a potential RNAi-based therapeutic.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.